Ligand Pharma (LGDN) Revenue

1 Followers

Ligand Pharma Revenue

Ligand Pharma had a revenue of 63.69M in the quarter ending Jun 30, 2026, with 23.14%. This bring the company's revenue in the last twelve months to 290.54M, Decreased 5.85%. In the fiscal year ending Dec 31, 2025, Ligand Pharma had annual revenue of 268.09M with 60.40% growth.

Revenue (ttm)

290.54M

Revenue Growth

44.47%

P/S Ratio

19.51

Revenue/Employee

€5,703,979

Employees

Market Cap

€5.23B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	268.09M	100.95M	+60.40%
Dec 31, 2024	167.13M	35.82M	+27.28%
Dec 31, 2023	131.31M	-64.93M	-33.09%
Dec 31, 2022	196.25M	-45.30M	-18.75%
Dec 31, 2021	241.54M	77.98M	+47.68%
Dec 31, 2020	163.56M	43.28M	+35.98%
Dec 31, 2019	120.28M	-131.17M	-52.17%
Dec 31, 2018	251.45M	110.35M	+78.21%
Dec 31, 2017	141.10M	―	―